6 trends tracked about this subject — the full history, oldest to newest below.
A new observational study links weight regain following the use of obesity medications to an increased risk of suicidal thoughts.
A new experimental weight loss injection has outperformed Mounjaro in a recent study, signaling a potential shift in obesity treatment.
The UK medicines regulator has approved a new once-daily weight-loss pill from Eli Lilly, offering an oral alternative to injectable GLP-1 treatments.
A new oral GLP-1 receptor agonist is emerging as a potent weight-loss alternative, outperforming oral Ozempic in recent clinical trials.
New evidence suggests combining structured exercise with GLP-1 therapies is essential for maximizing long-term health and economic value in obesity treatment.
New research indicates that patients taking GLP-1 weight loss drugs are reducing their physical activity levels.